W. Paul Bowman

Deletion of <i>IKZF1</i> and Prognosis in Acute Lymphoblastic Leukemia

Charles G. Mullighan, Xiaoping Su, Jinghui Zhang et al. · New England Journal of Medicine · 2009 · 1.4K citations · Full text

Life Sciences, Genetics, Hematology +15

Treating Childhood Acute Lymphoblastic Leukemia without Cranial Irradiation

Ching-Hon Pui, Dario Campana, Deqing Pei et al. · New England Journal of Medicine · 2009 · 1.2K citations · Full text

Medicine, Oncology, Pediatrics +12

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study

Michael J. Borowitz, Meenakshi Devidas, Stephen P. Hunger et al. · Blood · 2008 · 835 citations · Full text

Medicine, Oncology, Pediatrics +15

Improved Early Event-Free Survival With Imatinib in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Children's Oncology Group Study

Kirk R. Schultz, W. Paul Bowman, Alexander Aledo et al. · Journal of Clinical Oncology · 2009 · 709 citations · Full text

Medicine, Hematology, Oncology +16

Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial

Jeffrey E. Rubnitz, Hiroto Inaba, Gary V. Dahl et al. · The Lancet Oncology · 2010 · 581 citations

Medicine, Hematology, Oncology +16